Cian Healthcare share price
BSE: 542678Pharmaceuticals & BiotechnologySmall Cap
Last close ₹30.36up ₹0.59 (1.98%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.77.
52-week range of traded prices to 23 Oct 2026
₹4.72Low, 22 Dec 2025₹30.36High, 23 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹76 Cr4,297th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 Sep 2026
- 8.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 21 Sep 2026
- −113.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 Sep 2026
- 3.36
- Volume, BSEVolume. Shares traded on the last trading day.
- 685
Results
Standalone, as consolidated accounts are on record for only 7 of the last ten years; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 30 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹17 Crup 49.95%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹17 CrHalf year to Sep 2025: −₹4.19 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −99.1%
Revenue by year
Peak revenue ₹72 Cr, year to Mar 2021
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 4 of the 8 years shown
| ₹ crore | Sep 2022Filed 25 Nov | Mar 2023Filed 1 Jun | Sep 2023Filed 4 Dec | Mar 2024Filed 7 Aug | Sep 2024Filed 9 Apr | Mar 2025Filed 19 Jun | Sep 2025Filed 14 Nov | Mar 2026Filed 30 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34.8 | 32.7 | 30.6 | 28.1 | 18.5 | 12.3 | 11.3 | 17.0 |
| Net profit | −0.3 | 1.3 | −1.2 | 1.4 | −15.5 | −4.1 | −4.2 | −16.8 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −0.8% | 4.1% | −4.0% | 5.1% | −83.7% | −33.5% | −37.0% | −99.1% |
Standalone. The last eight half years. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Pharmaceutical, which carries all its revenue.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Cian Healthcare in market cap.
Cian Healthcare is not on the chart: it has no P/E today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Mercury LaboratoriesMERCURYLAB | 88 | 21.1 | 1.5 | 11.3 | −3.7% | +10.4% | 7.5% | 7.0% | 0.48% |
 Samrat PharmachemSAMRATPH | 86 | – | 1.3 | – | +4.7% | −145.8% | −3.2% | −2.7% | 0.00% |
 Denis Chem LabDENISCHEM | 83 | 10.4 | 0.9 | 3.5 | +4.1% | −5.8% | 9.0% | 10.4% | 4.17% |
 Vilin Bio MedVILINBIO | 78 | 40.3 | 2.7 | – | +185.4% | +763.0% | 7.5% | – | 0.00% |
 Shelter PharmaSHELTER | 75 | 8.3 | 1.0 | – | +44.4% | +24.7% | 15.1% | – | 0.00% |
 Sunil HealthcareSUNLOC | 71 | 19.9 | 1.0 | 10.0 | −0.6% | +1,851.4% | 5.2% | 4.9% | 0.00% |
 Source Natural Foods & Herbal SupplSOURCENTRL | 70 | 18.6 | 2.7 | 11.9 | +63.1% | +20.6% | 15.6% | 16.7% | 0.00% |
 Vineet LaboratoriesVINEETLAB | 70 | – | – | – | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
29 Sep · Meeting
29 Sep · Meeting
5 Sep · Disclosure Regarding Dispatch Of Letters To Those Shareholders Whose Email Addresses Are Not Registered With The Company/ Registrar And Transfer Agent And Depository Participants.
4 Sep · Meeting
2 Sep · Outcome Of The Meeting Of The Board Of Directors Of Cian Healthcare Limited Held On Wednesday, September 02, 2026.
2 Sep · Management
Cian Healthcare share price by year
Each calendar year to 2025.Cian Healthcare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 5.48 | +41.6% | 7.52 | 3.03 |
| 2024 | 3.87 | −77.3% | 25.00 | 3.87 |
| 2023 | 17.07 | −13.6% | 39.85 | 16.35 |
| 2022 | 19.75 | −7.1% | 33.65 | 12.55 |
| 2021 | 21.25 | +49.6% | 28.40 | 10.60 |
| 2020 | 14.20 | −12.9% | 25.13 | 10.60 |
| 2019 | 16.30 | – | 61.80 | 14.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2020 is from its first session, 17 Jan 2020. 2019 is from its first session, 23 May 2019.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 30.36 | 30.36 | 30.36 | 30.36 | 30.36 | 685 |
| 22 Oct 2026 | 29.77 | 29.77 | 29.77 | 29.77 | 29.77 | 137 |
| 21 Oct 2026 | 29.19 | 29.19 | 29.19 | 29.19 | 29.19 | 8,083 |
| 19 Oct 2026 | 28.62 | 28.62 | 28.62 | 28.62 | 28.62 | 137 |
| 16 Oct 2026 | 28.06 | 28.06 | 28.06 | 28.06 | 28.06 | 137 |
| 15 Oct 2026 | 27.51 | 27.51 | 27.51 | 27.51 | 27.51 | 137 |
| 14 Oct 2026 | 26.98 | 26.98 | 26.98 | 26.98 | 26.98 | 137 |
| 13 Oct 2026 | 26.46 | 26.46 | 26.46 | 26.46 | 26.46 | 7,124 |
| 9 Oct 2026 | 25.95 | 25.95 | 25.95 | 25.95 | 25.95 | 137 |
| 7 Oct 2026 | 25.45 | 25.45 | 25.45 | 25.45 | 25.45 | 274 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 9 Apr 2026 | Price move | – | This is the share's first trade after a corporate action (Resolution Plan -Suspension, ex-date 21 Jan 2026), and the action's terms do not account for the move. Not adjusted for. |
| 19 Aug 2024 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- Legal name
- Cian Healthcare Limited
- BSE code
- 542678
- ISIN
- INE05BN01027
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- May 2019
- Face value
- ₹10
- CIN
- L24233PN2003PLC017563
- Corporate identity number, the registrar of companies' code for it